73
Views
5
CrossRef citations to date
0
Altmetric
Short Report

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis

, , , &
Pages 415-420 | Published online: 05 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Paschalis Steiropoulos, Kostas Archontogeorgis, Evangelia Nena & Demosthenes Bouros. (2014) New developments in the management of COPD: clinical utility of indacaterol 75 μg. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1-7.
Read now
Andrea Rossi & Guido Polese. (2013) Indacaterol: a comprehensive review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 353-363.
Read now

Articles from other publishers (3)

Shannon Cope, James F Donohue, Jeroen P Jansen, Matthias Kraemer, Gorana Capkun-Niggli, Michael Baldwin, Felicity Buckley, Alexandra Ellis & Paul Jones. (2013) Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis. Respiratory Research 14:1.
Crossref
Vincent C. H. Chung, Polly H. X. Ma, David S. C. Hui, Wilson W. S. Tam & Jin Ling Tang. (2013) Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. PLoS ONE 8:8, pages e70784.
Crossref
Edward M. Kerwin & James Williams. (2013) Indacaterol 75 µg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective. Therapeutic Advances in Respiratory Disease 7:1, pages 25-37.
Crossref